The mRNA expression of the products of the inflammasome activation, such as IL-1β and IL-18, was overexpressed in COVID-19/B.1 patients (Figure 1; p < 0.0001 vs. control patients) and overexpressed in COVID-19/B.1.1.7 (Figure 1; p < 0.0001 vs. COVID-19/B.1 patients). This evidence concerns the gene IL1B and COVID-19.